Speece Thorson Capital Group Inc. lowered its stake in Steris PLC (NYSE:STE) by 0.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 129,429 shares of the medical equipment provider’s stock after selling 921 shares during the period. Steris accounts for approximately 2.2% of Speece Thorson Capital Group Inc.’s holdings, making the stock its 22nd biggest holding. Speece Thorson Capital Group Inc.’s holdings in Steris were worth $11,321,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in STE. Meeder Asset Management Inc. increased its position in shares of Steris by 1,122.4% in the 4th quarter. Meeder Asset Management Inc. now owns 1,198 shares of the medical equipment provider’s stock worth $104,000 after purchasing an additional 1,100 shares during the last quarter. Zions Bancorporation bought a new stake in shares of Steris in the 3rd quarter worth about $178,000. Citigroup Inc. bought a new stake in shares of Steris in the 2nd quarter worth about $206,000. Oakbrook Investments LLC bought a new stake in shares of Steris in the 4th quarter worth about $271,000. Finally, GSA Capital Partners LLP bought a new stake in shares of Steris in the 3rd quarter worth about $284,000. 89.47% of the stock is owned by institutional investors.

Shares of Steris PLC (NYSE STE) opened at $85.45 on Wednesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.22 and a current ratio of 2.82. Steris PLC has a 1 year low of $67.55 and a 1 year high of $93.71. The firm has a market cap of $7,285.06, a PE ratio of 30.05 and a beta of 1.22.

Steris (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.05. The business had revenue of $661.90 million during the quarter, compared to the consensus estimate of $663.17 million. Steris had a net margin of 9.42% and a return on equity of 11.57%. The company’s revenue for the quarter was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.98 EPS. research analysts expect that Steris PLC will post 4.13 earnings per share for the current year.

STE has been the subject of a number of recent research reports. KeyCorp reaffirmed a “buy” rating and set a $103.00 price objective on shares of Steris in a research report on Thursday, February 8th. TD Securities boosted their price objective on shares of Steris from C$14.00 to C$16.00 and gave the company a “buy” rating in a research report on Thursday, November 9th. Zacks Investment Research raised shares of Steris from a “hold” rating to a “buy” rating and set a $103.00 price objective for the company in a research report on Tuesday, January 23rd. Northcoast Research set a $102.00 price objective on shares of Steris and gave the company a “buy” rating in a research report on Thursday, February 8th. Finally, Raymond James Financial reaffirmed a “market perform” rating and set a $100.00 price objective on shares of Steris in a research report on Wednesday, January 3rd. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $84.80.

In other Steris news, VP Sudhir K. Pahwa sold 2,000 shares of the business’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $92.09, for a total transaction of $184,180.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.55% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2018/02/14/steris-plc-ste-shares-sold-by-speece-thorson-capital-group-inc.html.

Steris Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.